TLDR: Johns Hopkins Technology Ventures has announced the recipients of its 2025 President’s Venture Fellowship and Innovation & Entrepreneurship Challenge. The awards highlight two key innovations: Fetal Therapy Technologies, which developed a novel port system for fetal surgeries, and Modelus, an AI-driven platform designed to accelerate drug development. A significant achievement this year is the unprecedented recognition of women-led teams, who secured both President’s Venture Fellowship awards.
Johns Hopkins Technology Ventures (JHTV) has proudly unveiled the recipients of its prestigious 2025 President’s Venture Fellowship (PVF) and the Innovation & Entrepreneurship (I&E) Challenge. These awards underscore the institution’s commitment to fostering groundbreaking ideas and supporting ventures poised to address complex real-world challenges, originating from its diverse student body. A notable highlight of this year’s awards is the unprecedented achievement of women-led teams, who secured both PVF awards, marking a significant milestone in Johns Hopkins’ dedication to inclusive innovation within its entrepreneurial ecosystem.
Among the distinguished PVF honorees is Fetal Therapy Technologies, a team that has developed a novel port system specifically designed for fetal surgeries. This innovative initiative, which began as an undergraduate project, is now set to significantly advance maternal-fetal care. The technology aims to address the intricate demands of in-utero surgical procedures by providing a more efficient and safer access point for instruments, with the potential to reduce complications and improve outcomes for both mother and child.
The second PVF award was granted to Modelus, a pioneering team leveraging artificial intelligence (AI) to expedite drug development processes. Comprising talented students from both The Johns Hopkins University’s Carey Business School and the Johns Hopkins Whiting School of Engineering, Modelus is directly tackling the inherent inefficiencies in pharmaceutical research and development. By employing advanced AI algorithms to analyze vast datasets, identify promising compounds, and predict their efficacy, Modelus promises to streamline the pathway for new therapeutic discoveries, addressing the notoriously time-consuming and expensive nature of drug discovery.
Also Read:
- Medical Education’s AI Lag: A Critical Gap in Preparing Future Physicians
- AI’s Growing Role in Health Diagnosis: A Double-Edged Sword for Americans and Clinicians
These selected ventures exemplify a compelling synthesis of academic rigor and practical application, showcasing the strategic emphasis Johns Hopkins places on cultivating innovation that translates into tangible societal benefits. The support provided through these awards is crucial for emerging innovators, serving as a critical impetus for their ventures to move from concept to impactful reality.
